What will it take to develop new drugs for Lyme disease?

|

November 17, 2021

Dr. Ray Stricker

Dr. Raphael Stricker, a San Francisco internist and hematologist, is an internationally recognized leader in tick-borne disease diagnosis and treatment.

He is also a board member of LymeDisease.org.

Dr. Stricker recently delivered a recorded overview of tick-borne diseases to the European Society of Medicine Congress 2021. The title of his talk was “Lyme Disease: The New Pharma Frontier.”

As he notes in his introduction, “Over the past year, there have been at least four novel antiviral drugs for Covid-19 that have been developed. It’s disappointing that we haven’t seen the same kind of drug development for Lyme disease over the years. [In this presentation], I’d like to focus on that type of drug development.”

Click below to view his talk.

Dorothy Leland
Written by

Dorothy Leland

Dorothy Leland is a longtime advocate and researcher focused on Lyme disease education, policy awareness, and patient support. She has contributed to numerous publications and works closely with medical professionals and organizations to improve understanding and treatment of tick-borne diseases.

Do You Have Lyme Disease?

Use our symptom checklist to better understand possible Lyme disease signs and next steps.

Newsletter Sign-up

Support LymeDisease.org

Your support helps us advocate for patients and fund critical Lyme disease research.

Related Articles